Position in INSM
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$18,979,602
+$1,434,282 QoQ
Shares Held
116,069
+15.1% QoQ
Ownership
0.054%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in INSM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Rafferty Asset Management, LLC holds $409,131,400 across 136 Biotechnology names. INSM ranks #3 (4.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
54,572 | $24,368,580 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
29,589 | $22,861,644 | |
| 3 | INSM |
INSMED Inc
This page
|
116,069 | $18,979,602 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
50,553 | $16,726,471 | |
| 5 | APLS |
Apellis Pharmaceuticals, Inc.
|
180,471 | $7,260,348 | |
| 6 | MRNA |
Moderna, Inc.
|
114,194 | $5,801,055 | |
| 7 | INCY |
Incyte Corp
|
60,565 | $5,700,377 | |
| 8 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
10,452 | $5,471,308 |
All Filings in INSM
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $18,979,602 | 116,069 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $17,545,320 | 100,812 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $7,943,447 | 55,159 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $9,873,790 | 98,110 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $11,137,119 | 145,984 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $12,490,233 | 180,913 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $16,556,400 | 226,800 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $7,518,338 | 112,214 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $8,942,997 | 329,635 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $9,950,486 | 321,087 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $6,906,481 | 273,524 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $7,830,758 | 371,126 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $6,449,128 | 378,248 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $8,727,303 | 436,802 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $6,011,383 | 279,080 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $3,612,211 | 183,175 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $5,675,250 | 241,500 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $5,443,015 | 199,817 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $3,160,875 | 114,774 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $2,469,730 | 86,779 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $2,901,230 | 85,180 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $778,020 | 23,371 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $2,239,675 | 69,685 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $967,232 | 35,121 | Shares | Sole | 2020-08-07 | |
| 2020-03-31 | $162,239 | 10,121 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||